2Seventy Bio Financials
| TSVT Stock | USD 2.61 0.17 6.97% |
2Seventy |
Please note, the imprecision that can be found in 2Seventy Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 2Seventy Bio. Check 2Seventy Bio's Beneish M Score to see the likelihood of 2Seventy Bio's management manipulating its earnings.
2Seventy Bio Stock Summary
2Seventy Bio competes with Puma Biotechnology, Iovance Biotherapeutics, Sarepta Therapeutics, Day One, and Inozyme Pharma. 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US9013841070 |
| CUSIP | 901384107 |
| Location | Massachusetts; U.S.A |
| Business Address | 60 Binney Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.2seventybio.com |
| Phone | 617 675 7270 |
| Currency | USD - US Dollar |
2Seventy Bio Key Financial Ratios
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.19 | ||||
| Target Price | 6.75 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.79 |
2Seventy Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 2Seventy Bio's current stock value. Our valuation model uses many indicators to compare 2Seventy Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 2Seventy Bio competition to find correlations between indicators driving 2Seventy Bio's intrinsic value. More Info.2Seventy Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value 2Seventy Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.2Seventy Bio Systematic Risk
2Seventy Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 2Seventy Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on 2Seventy Bio correlated with the market. If Beta is less than 0 2Seventy Bio generally moves in the opposite direction as compared to the market. If 2Seventy Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one 2Seventy Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 2Seventy Bio is generally in the same direction as the market. If Beta > 1 2Seventy Bio moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as 2Seventy Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of 2Seventy has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if 2Seventy Bio's financials are consistent with your investment objective using the following steps:- Review 2Seventy Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand 2Seventy Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare 2Seventy Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if 2Seventy Bio's stock is overvalued or undervalued.
2Seventy Bio January 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of 2Seventy Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 2Seventy Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of 2Seventy Bio based on widely used predictive technical indicators. In general, we focus on analyzing 2Seventy Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 2Seventy Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 24.7 | |||
| Value At Risk | (7.48) | |||
| Potential Upside | 7.32 |
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.